These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17435680)

  • 1. Genetic background of carcinogenesis in the thyroid gland.
    Lewiński A; Wojciechowska K
    Neuro Endocrinol Lett; 2007 Apr; 28(2):77-105. PubMed ID: 17435680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of genetic factors in the pathogenesis of thyroid neoplasms].
    Ferenc T; Maciaszczyk K; Gesing A; Lewiński A
    Postepy Hig Med Dosw; 1997; 51(4):367-84. PubMed ID: 9446100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biology of thyroid neoplasms.
    Satta MA; Nanni S; Della Casa S; Pontecorvi A
    Rays; 2000; 25(2):151-61. PubMed ID: 11370534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis.
    Iuliano R; Le Pera I; Cristofaro C; Baudi F; Arturi F; Pallante P; Martelli ML; Trapasso F; Chiariotti L; Fusco A
    Oncogene; 2004 Nov; 23(52):8432-8. PubMed ID: 15378013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin receptor: a role for thyroid tumourigenesis?
    Russo D; Arturi F; Chiefari E; Filetti S
    Forum (Genova); 1999; 9(2):166-75. PubMed ID: 10385711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic dysregulation in thyroid neoplasia.
    Kondo T; Asa SL; Ezzat S
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An epitome of DNA repair related genes and mechanisms in thyroid carcinoma.
    Gatzidou E; Michailidi C; Tseleni-Balafouta S; Theocharis S
    Cancer Lett; 2010 Apr; 290(2):139-47. PubMed ID: 19709803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis of thyroid nodules and cancer.
    Moretti F; Nanni S; Pontecorvi A
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):517-39. PubMed ID: 11289733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
    Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
    J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medullary thyroid carcinoma and some of its particularities].
    Sidibé el H
    Sante; 2007; 17(1):51-5. PubMed ID: 17897902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid tumorigenesis and molecular markers in thyroid cancer.
    Kouniavsky G; Zeiger MA
    Curr Opin Oncol; 2010 Jan; 22(1):23-9. PubMed ID: 19907326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.
    Cerrato A; De Falco V; Santoro M
    J Mol Endocrinol; 2009 Oct; 43(4):143-55. PubMed ID: 19383830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation status of genes in papillary thyroid carcinoma.
    Smith JA; Fan CY; Zou C; Bodenner D; Kokoska MS
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1006-11. PubMed ID: 17938324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Geographical differences of thyroid carcinoma and basic molecular principles].
    Goretzki PE; Witte J; Dotzenrath C; Schulte KM; Simon D; Röher HD
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():200-2. PubMed ID: 9931611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations in gallbladder carcinoma.
    Kuroki T; Tajima Y; Matsuo K; Kanematsu T
    Surg Today; 2005; 35(2):101-5. PubMed ID: 15674488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in thyroid cancer: the role of mouse models.
    Knostman KA; Jhiang SM; Capen CC
    Vet Pathol; 2007 Jan; 44(1):1-14. PubMed ID: 17197619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
    Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
    Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intragenic mutations in thyroid cancer.
    Sobrinho-Simões M; Máximo V; Rocha AS; Trovisco V; Castro P; Preto A; Lima J; Soares P
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):333-62, viii. PubMed ID: 18502330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.